Advances in HIV 2020    

Friday, July 10, 2020 at 1:00 PM EDT (WEBCAST)

Speaker:

 
 

Michael G. Sension, MD

Medical Director

CAN Community Health

Internal Medicine

Ft. Lauderdale, FL

 

 

 

Sension_DHHS  



 
  
     
Scoll down to access the program LOG-IN window at the bottom of this page!
 

Target Audience

This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.

 

Learning Objectives

Upon completion of theactivity, participants should be better able to: 

• Utilize current and emerging data on HIV therapies and treatment paradigms to improve the treatment of HIV-positive patients
• Address and reduce side effects from ARVs that can interfere with adherence to ARV regimens
• Understand and apply in a clinical setting information about new paradigms and approaches to treating and managing HIV, including potential two-drug ARV combinations
• Provide rapid initiation of ARV therapy following an HIV diagnosis
• Apply new and emerging information on long-acting ARVs to their clinical practice
• Discuss future directions in HIV treatment and HIV cure research  

 Joint Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and ViralEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians 


Disclosure of Conflicts of Interest 

As aprovider accredited by the ACCME, The University of Chicago Pritzker School ofMedicine, requires everyone who is in a position to control the content of aneducation activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling,or distributing health care goods or services consumed by, or used on,patients. The ACCME defines "relevant financial relationships" asfinancial relationships in any amount, occurring within the past 12 months,including financial relationships of a spouse or life partner that could createa conflict of interest. Mechanisms are in place to identify and resolve anypotential conflict of interest prior to the start of the activity.  

Additionally,The University of Chicago Pritzker School of Medicine requires authors toidentify investigational products or off-label uses of products regulated bythe US Food and Drug Administration at first mention and where appropriate inthe content. 

Joseph Eron, MD

   •Consulting Fees: Gilead, ViiV, Merck

   •Contracted Research: Gilead, ViiV, Janssen  

Ian Frank, MD

   •Consulting Fees: Gilead, GSK

   •Contracted Research: Johnson & Johnson  

Paul Sax, MD

   •Consulting Fees: Gilead, GSK/ViiV, Merck, Janssen

   •Contracted Research: Gilead, Merck, GSK/ViiV

  •Editorial Positions: UpToDate, Medscape, NEJM Journal Watch, Open Forum Infectious Diseases 

Renlsow Sherer, MD

   •Nothing to Disclose

University of Chicago Center forContinuing Medical Education and ViralEd, Inc Declarations
The staff of theCenter for Continuing Medical Education and Viral Ed Inc. have no financialrelationships to disclose.

Michael Sension, MD

•Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers' bureaus): Gilead, ViiV, Janssen

Disclaimer

The views expressed in this activity arethose of the individual speaker. It should not be inferred or assumed that theyare expressing the views of any pharmaceutical or product/device manufacturer,provider of commercial services, or The University of Chicago. The drugselection and dosage information presented in this activity are believed to beaccurate. However, participants are urged to consult the full prescribinginformation on any agent(s) presented in this activity for recommended dosage,indications, contraindications, warnings, precautions, and adverse effectsbefore prescribing any medication. This is particularly important when a drugis new or infrequently prescribed. 

Copyright © 2020 University of Chicago.All rights reserved including translation into other languages. No part of thisactivity may be reproduced or transmitted in any form or by any means,electronic or mechanical, including photocopying, recording, or any informationstorage and retrieval systems, without permission in writing from TheUniversity of Chicago Center for Continuing Medical Education.

 

 

FILL OUT THE FORM BELOW TO JOIN OUR PROGRAM

 

Advances in HIV/AIDS - 7/10/20
Your name *
Email address *
Degree/Profession *
Country *
How many participants are watching using your internet connection? *
 
* Required